Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
Issa AM, Thorogood A, Joly Y, Knoppers BM, “Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations” (2019) 21:3 Genetics in Medicine, 542-544.
Ce contenu a été mis à jour le 1 octobre 2019 à 11 h 55 min.